• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙型肝炎病毒(HCV)RNA在对α干扰素治疗呈现长期持续应答的慢性丙型肝炎患者中的临床意义

Clinical significance of hepatic HCV RNA in patients with chronic hepatitis C demonstrating long-term sustained response to interferon-alpha therapy.

作者信息

Larghi A, Tagger A, Crosignani A, Ribero M L, Bruno S, Portera G, Battezzati P M, Maggioni M, Fasola M, Zuin M, Podda M

机构信息

Department of Internal Medicine, Ospedale San Paolo, Milan, Italy.

出版信息

J Med Virol. 1998 May;55(1):7-11.

PMID:9580879
Abstract

Whether sustained biochemical response and absence of serum HCV RNA in the 6-12 months following suspension of interferon-alpha (IFN-alpha) therapy reflect definitive viral clearance in patients with chronic hepatitis C virus (HCV) infection is controversial. To obtain more information on this topic, HCV RNA was sought in both liver and serum samples of 25 long-term responders who were followed for a median period of 39 months (range 21-79) after discontinuation of IFN-alpha. Liver biopsy was undertaken before and 6 to 12 months after IFN-alpha withdrawal. Liver and serum HCV RNA were tested by a nested polymerase chain reaction. Twenty-two patients (88%) tested negative for both liver and serum HCV RNA, two patients had detectable HCV RNA in both liver and serum, and one patient showed persistent HCV RNA only in the liver. Post-treatment liver histology improved markedly in all patients, including those with viral persistence. During further follow-up, biochemical remission was maintained in all patients except one in whom both serum and liver specimens remained HCV RNA positive. The data indicate that the large majority of long-term responders test negative for HCV RNA in the liver, which suggests definitive eradication of HCV RNA infection.

摘要

在慢性丙型肝炎病毒(HCV)感染患者中,停止使用α干扰素(IFN-α)治疗后的6 - 12个月内持续的生化反应及血清HCV RNA的缺失是否反映病毒被彻底清除存在争议。为了获取关于该主题的更多信息,我们对25名长期缓解者的肝脏和血清样本进行了HCV RNA检测,这些患者在停用IFN-α后接受了为期39个月(范围21 - 79个月)的中位随访。在停用IFN-α之前以及之后6至12个月进行了肝活检。通过巢式聚合酶链反应检测肝脏和血清中的HCV RNA。22名患者(88%)的肝脏和血清HCV RNA检测均为阴性,2名患者的肝脏和血清中均可检测到HCV RNA,1名患者仅在肝脏中显示持续的HCV RNA。所有患者,包括病毒持续存在的患者,治疗后的肝脏组织学均有明显改善。在进一步随访期间,除1名患者血清和肝脏标本HCV RNA均为阳性外,所有患者均维持生化缓解。数据表明,绝大多数长期缓解者肝脏中的HCV RNA检测为阴性,这提示HCV RNA感染被彻底根除。

相似文献

1
Clinical significance of hepatic HCV RNA in patients with chronic hepatitis C demonstrating long-term sustained response to interferon-alpha therapy.丙型肝炎病毒(HCV)RNA在对α干扰素治疗呈现长期持续应答的慢性丙型肝炎患者中的临床意义
J Med Virol. 1998 May;55(1):7-11.
2
Complete eradication of hepatitis C virus after interferon treatment for chronic hepatitis C.慢性丙型肝炎患者接受干扰素治疗后丙型肝炎病毒的完全清除。
Ital J Gastroenterol Hepatol. 1997 Jun;29(3):255-61.
3
Late disappearance of hepatitis C virus RNA from peripheral blood mononuclear cells in patients with chronic hepatitis C in sustained response after alpha-interferon therapy.慢性丙型肝炎患者在接受α干扰素治疗后获得持续应答时,外周血单个核细胞中丙型肝炎病毒RNA的延迟消失
Am J Gastroenterol. 1999 Jul;94(7):1902-5. doi: 10.1111/j.1572-0241.1999.01227.x.
4
Interferon therapy in hemodialysis patients with chronic hepatitis C virus infection induces a high rate of long-term sustained virological and biochemical response.干扰素治疗慢性丙型肝炎病毒感染的血液透析患者可诱导较高的长期持续病毒学和生化应答率。
Clin Nephrol. 2001 Mar;55(3):220-6.
5
Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.儿童慢性丙型肝炎干扰素α治疗效果的研究。
Med Sci Monit. 2000 Sep-Oct;6(5):964-70.
6
Chronic hepatitis C virus infection in renal transplant: treatment and outcome.肾移植受者的慢性丙型肝炎病毒感染:治疗与转归
Clin Transplant. 2006 Nov-Dec;20(6):677-83. doi: 10.1111/j.1399-0012.2006.00534.x.
7
Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy.慢性丙型肝炎患者对干扰素治疗反应不同,肝硬化和肝细胞癌的发病率各异。
Cancer. 1999 May 1;85(9):1943-50.
8
Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.干扰素-α与利巴韦林治疗丙型肝炎病毒相关的系统性血管炎患者。
Arthritis Rheum. 2002 Dec;46(12):3317-26. doi: 10.1002/art.10699.
9
Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.成功治疗慢性丙型肝炎患者后丙型肝炎病毒的清除
Gastroenterology. 2008 Sep;135(3):821-9. doi: 10.1053/j.gastro.2008.05.044. Epub 2008 May 21.
10
Evaluation of molecular parameters for routine assessment of viremia in patients with chronic hepatitis C who are undergoing antiviral therapy.评估接受抗病毒治疗的慢性丙型肝炎患者病毒血症常规评估的分子参数。
J Hum Virol. 1998 Jul-Aug;1(5):314-9.

引用本文的文献

1
Living donor liver transplantation from a donor previously treated with interferon for hepatitis C virus: a case report.来自曾接受干扰素治疗丙型肝炎病毒的供体的活体肝移植:一例报告。
J Med Case Rep. 2011 Jul 3;5:276. doi: 10.1186/1752-1947-5-276.
2
Long-term outcomes of chronic hepatitis C patients with sustained virological response at 6 months after the end of treatment.治疗结束6个月时获得持续病毒学应答的慢性丙型肝炎患者的长期预后
World J Gastroenterol. 2006 Sep 14;12(34):5532-5. doi: 10.3748/wjg.v12.i34.5532.
3
High versus standard doses interferon-alpha in the treatment of naïve chronic hepatitis C patients in Taiwan: a 10-year cohort study.
高剂量与标准剂量干扰素-α治疗台湾初治慢性丙型肝炎患者的10年队列研究
BMC Infect Dis. 2005 Apr 12;5:27. doi: 10.1186/1471-2334-5-27.